Skip to content

Opening book details…

About this Medicine article

A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer by Oh, S C; Sur, H Y; Sung, H J; Choi, I K; Park, S S; Seo, J H; Jeen, Y T; Chun, H J; Shin, S W; Mok, Y J is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Oh, S C; Sur, H Y; Sung, H J; Choi, I K; Park, S S; Seo, J H; Jeen, Y T; Chun, H J; Shin, S W; Mok, Y J
Publisher
Nature Publishing Group; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0007-0920)
Published
2007
Field
Medicine (Health Sciences)

More by Oh, S C; Sur, H Y; Sung, H J; Choi, I K; Park, S S; Seo, J H; Jeen, Y T; Chun, H J; Shin, S W; Mok, Y J

Browse all works by Oh, S C; Sur, H Y; Sung, H J; Choi, I K; Park, S S; Seo, J H; Jeen, Y T; Chun, H J; Shin, S W; Mok, Y J